Barbara A. Bennett

Family Medicine

38 Woodcroft Trl
Beavercreek, OH 45430

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study.

Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study.

Journal: PloS one

Published: July 06, 2012

Showing 1-1 of 1

Last Updated: 09/26/2026